Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies.

Rosillon D, Baril L, Del Rosario-Raymundo MR, Wheeler CM, Skinner SR, Garland SM, Salmeron J, Lazcano-Ponce E, Vallejos CS, Stoney T, Ter Harmsel B, Lim TYK, Quek SC, Minkina G, McNeil SA, Bouchard C, Fong KL, Money D, Ilancheran A, Savicheva A, Cruickshank M, Chatterjee A, Fiander A, Martens M, Bozonnat MC, Struyf F, Dubin G, Castellsagué X.

Cancer Med. 2019 Jul 5. doi: 10.1002/cam4.1879. [Epub ahead of print]

2.

Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak report.

Randremanana R, Andrianaivoarimanana V, Nikolay B, Ramasindrazana B, Paireau J, Ten Bosch QA, Rakotondramanga JM, Rahajandraibe S, Rahelinirina S, Rakotomanana F, Rakotoarimanana FM, Randriamampionona LB, Razafimbia V, De Dieu Randria MJ, Raberahona M, Mikaty G, Le Guern AS, Rakotonjanabelo LA, Ndiaye CF, Rasolofo V, Bertherat E, Ratsitorahina M, Cauchemez S, Baril L, Spiegel A, Rajerison M.

Lancet Infect Dis. 2019 May;19(5):537-545. doi: 10.1016/S1473-3099(18)30730-8. Epub 2019 Mar 28.

3.

Introducing new vaccines in low- and middle-income countries: challenges and approaches.

Guignard A, Praet N, Jusot V, Bakker M, Baril L.

Expert Rev Vaccines. 2019 Feb;18(2):119-131. doi: 10.1080/14760584.2019.1574224. Epub 2019 Feb 11. Review.

PMID:
30689472
4.

Healthcare utilization, provisioning of post-exposure prophylaxis, and estimation of human rabies burden in Madagascar.

Rajeev M, Edosoa G, Hanitriniaina C, Andriamandimby SF, Guis H, Ramiandrasoa R, Ratovoson R, Randrianasolo L, Andriamananjara M, Heraud JM, Baril L, Metcalf CJE, Hampson K.

Vaccine. 2018 Nov 30. pii: S0264-410X(18)31520-2. doi: 10.1016/j.vaccine.2018.11.011. [Epub ahead of print]

5.

Reply to Lee et al.'s letter to the editor pertaining to our publication entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review".

Willame C, Lin L, Vetter V, Baril L, Praet N.

Vaccine. 2018 Oct 29;36(45):6589-6590. doi: 10.1016/j.vaccine.2018.08.025. No abstract available.

6.

Plague: Bridging gaps towards better disease control.

D'Ortenzio E, Lemaître N, Brouat C, Loubet P, Sebbane F, Rajerison M, Baril L, Yazdanpanah Y.

Med Mal Infect. 2018 Aug;48(5):307-317. doi: 10.1016/j.medmal.2018.04.393. Epub 2018 Jun 1. Review.

PMID:
29773334
7.

Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials.

Safaeian M, Castellsagué X, Hildesheim A, Wacholder S, Schiffman MH, Bozonnat MC, Baril L, Rosillon D; Costa Rica HPV Vaccine Trial and the PATRICIA study groups .

J Infect Dis. 2018 Jun 5;218(1):84-94. doi: 10.1093/infdis/jiy112.

8.

Pain caused by measles, mumps, and rubella vaccines: A systematic literature review.

Willame C, Henry O, Lin L, Vetter V, Baril L, Praet N.

Vaccine. 2017 Oct 9;35(42):5551-5558. doi: 10.1016/j.vaccine.2017.08.068. Review.

9.

Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view.

Cohet C, Rosillon D, Willame C, Haguinet F, Marenne MN, Fontaine S, Buyse H, Bauchau V, Baril L.

Vaccine. 2017 May 25;35(23):3041-3049. doi: 10.1016/j.vaccine.2017.04.058. Epub 2017 Apr 29.

10.

Importance of feasibility assessments before implementing non-interventional pharmacoepidemiologic studies of vaccines: lessons learned and recommendations for future studies.

Willame C, Baril L, van den Bosch J, Ferreira GL, Williams R, Rosillon D, Cohet C.

Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1397-1406. doi: 10.1002/pds.4081. Epub 2016 Sep 7.

11.

Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom.

Willame C, Rosillon D, Zima J, Angelo MG, Stuurman AL, Vroling H, Boggon R, Bunge EM, Pladevall-Vila M, Baril L.

Hum Vaccin Immunother. 2016 Nov;12(11):2862-2871. Epub 2016 Jul 18.

12.

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.

Skinner SR, Wheeler CM, Romanowski B, Castellsagué X, Lazcano-Ponce E, Del Rosario-Raymundo MR, Vallejos C, Minkina G, Pereira Da Silva D, McNeil S, Prilepskaya V, Gogotadze I, Money D, Garland SM, Romanenko V, Harper DM, Levin MJ, Chatterjee A, Geeraerts B, Struyf F, Dubin G, Bozonnat MC, Rosillon D, Baril L; VIVIANE Study Group.

Int J Cancer. 2016 May 15;138(10):2428-38. doi: 10.1002/ijc.29971.

13.

From current vaccine recommendations to everyday practices: An analysis in five sub-Saharan African countries.

Delrieu I, Gessner BD, Baril L, Roset Bahmanyar E.

Vaccine. 2015 Dec 16;33(51):7290-7298. doi: 10.1016/j.vaccine.2015.10.107. Epub 2015 Nov 3.

14.

Risk factors associated with asthma, atopic dermatitis and rhinoconjunctivitis in a rural Senegalese cohort.

Herrant M, Loucoubar C, Boufkhed S, Bassène H, Sarr FD, Baril L, Mercereau-Puijalon O, Mécheri S, Sakuntabhai A, Paul R.

Allergy Asthma Clin Immunol. 2015 Aug 25;11(1):24. doi: 10.1186/s13223-015-0090-0. eCollection 2015.

15.

Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom.

Baril L, Rosillon D, Willame C, Angelo MG, Zima J, van den Bosch JH, Van Staa T, Boggon R, Bunge EM, Hernandez-Diaz S, Chambers CD.

Vaccine. 2015 Nov 27;33(48):6884-91. doi: 10.1016/j.vaccine.2015.07.024. Epub 2015 Jul 21.

16.

Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?

Michel R, Berger F, Ravelonarivo J, Dussart P, Dia M, Nacher M, Rogier S, Moua D, Sarr FD, Diop OM, Sall AA, Baril L.

Vaccine. 2015 May 11;33(20):2301-6. doi: 10.1016/j.vaccine.2015.03.069. Epub 2015 Apr 2.

PMID:
25843268
17.

Strategies for continuous evaluation of the benefit-risk profile of HPV-16/18-AS04-adjuvanted vaccine.

Angelo MG, Taylor S, Struyf F, Tavares Da Silva F, Arellano F, David MP, Dubin G, Rosillon D, Baril L.

Expert Rev Vaccines. 2014 Nov;13(11):1297-306. doi: 10.1586/14760584.2014.959931. Epub 2014 Sep 14. Review.

PMID:
25219284
18.

Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience.

Angelo MG, Zima J, Tavares Da Silva F, Baril L, Arellano F.

Pharmacoepidemiol Drug Saf. 2014 May;23(5):456-65. doi: 10.1002/pds.3593. Epub 2014 Feb 20. Review.

19.

Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme.

Angelo MG, David MP, Zima J, Baril L, Dubin G, Arellano F, Struyf F.

Pharmacoepidemiol Drug Saf. 2014 May;23(5):466-79. doi: 10.1002/pds.3554. Epub 2014 Feb 20.

20.

Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.

Castellsagué X, Naud P, Chow SN, Wheeler CM, Germar MJ, Lehtinen M, Paavonen J, Jaisamrarn U, Garland SM, Salmerón J, Apter D, Kitchener H, Teixeira JC, Skinner SR, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, de Carvalho NS, Peters K, Tjalma WA, Safaeian M, Raillard A, Descamps D, Struyf F, Dubin G, Rosillon D, Baril L.

J Infect Dis. 2014 Aug 15;210(4):517-34. doi: 10.1093/infdis/jiu139. Epub 2014 Mar 8.

21.

Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.

Castellsagué X, Paavonen J, Jaisamrarn U, Wheeler CM, Skinner SR, Lehtinen M, Naud P, Chow SN, Del Rosario-Raymundo MR, Teixeira JC, Palmroth J, de Carvalho NS, Germar MJ, Peters K, Garland SM, Szarewski A, Poppe WA, Romanowski B, Schwarz TF, Tjalma WA, Bosch FX, Bozonnat MC, Struyf F, Dubin G, Rosillon D, Baril L; HPV PATRICIA Study Group.

BMC Infect Dis. 2014 Oct 30;14:551. doi: 10.1186/s12879-014-0551-y.

22.

Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.

Jaisamrarn U, Castellsagué X, Garland SM, Naud P, Palmroth J, Del Rosario-Raymundo MR, Wheeler CM, Salmerón J, Chow SN, Apter D, Teixeira JC, Skinner SR, Hedrick J, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, de Carvalho NS, Germar MJ, Peters K, Paavonen J, Bozonnat MC, Descamps D, Struyf F, Dubin GO, Rosillon D, Baril L; HPV PATRICIA Study Group.

PLoS One. 2013 Nov 19;8(11):e79260. doi: 10.1371/journal.pone.0079260. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/cea59317-929c-464a-b3f7-e095248f229a.

23.

Asthma and atopic dermatitis are associated with increased risk of clinical Plasmodium falciparum malaria.

Herrant M, Loucoubar C, Bassène H, Gonçalves B, Boufkhed S, Diene Sarr F, Fontanet A, Tall A, Baril L, Mercereau-Puijalon O, Mécheri S, Sakuntabhai A, Paul R.

BMJ Open. 2013 Jul 24;3(7). pii: e002835. doi: 10.1136/bmjopen-2013-002835. Print 2013.

24.

Clinical and virological study of dengue cases and the members of their households: the multinational DENFRAME Project.

Dussart P, Baril L, Petit L, Beniguel L, Quang LC, Ly S, Azevedo Rdo S, Meynard JB, Vong S, Chartier L, Diop A, Sivuth O, Duong V, Thang CM, Jacobs M, Sakuntabhai A, Nunes MR, Huong VT, Buchy P, Vasconcelos PF.

PLoS Negl Trop Dis. 2012 Jan;6(1):e1482. doi: 10.1371/journal.pntd.0001482. Epub 2012 Jan 24.

25.

Songbird response to increased willow (Salix spp.) growth in Yellowstone's northern range.

Baril LM, Hansen AJ, Renkin R, Lawrence R.

Ecol Appl. 2011 Sep;21(6):2283-96.

PMID:
21939061
26.

Allelic diversity of the Plasmodium falciparum erythrocyte membrane protein 1 entails variant-specific red cell surface epitopes.

Vigan-Womas I, Guillotte M, Juillerat A, Vallieres C, Lewit-Bentley A, Tall A, Baril L, Bentley GA, Mercereau-Puijalon O.

PLoS One. 2011 Jan 27;6(1):e16544. doi: 10.1371/journal.pone.0016544.

27.

Heritability of the human infectious reservoir of malaria parasites.

Lawaly YR, Sakuntabhai A, Marrama L, Konate L, Phimpraphi W, Sokhna C, Tall A, Sarr FD, Peerapittayamongkol C, Louicharoen C, Schneider BS, Levescot A, Talman A, Casademont I, Menard D, Trape JF, Rogier C, Kaewkunwal J, Sura T, Nuchprayoon I, Ariey F, Baril L, Singhasivanon P, Mercereau-Puijalon O, Paul R.

PLoS One. 2010 Jun 29;5(6):e11358. doi: 10.1371/journal.pone.0011358.

28.

Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal.

Ly AB, Tall A, Perry R, Baril L, Badiane A, Faye J, Rogier C, Touré A, Sokhna C, Trape JF, Michel R.

Malar J. 2010 Jun 4;9:153. doi: 10.1186/1475-2875-9-153.

29.

Viral etiology of respiratory infections in children under 5 years old living in tropical rural areas of Senegal: The EVIRA project.

Niang MN, Diop OM, Sarr FD, Goudiaby D, Malou-Sompy H, Ndiaye K, Vabret A, Baril L.

J Med Virol. 2010 May;82(5):866-72. doi: 10.1002/jmv.21665.

PMID:
20336732
30.

Whole-cell pertussis vaccine induces low antibody levels in human immunodeficiency virus-infected children living in sub-Saharan Africa.

Tejiokem MC, Njamkepo E, Gouandjika I, Rousset D, Béniguel L, Bilong C, Tene G, Penda I, Ngongueu C, Gody JC, Guiso N, Baril L.

Clin Vaccine Immunol. 2009 Apr;16(4):479-83. doi: 10.1128/CVI.00312-08. Epub 2009 Feb 4.

31.

An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype.

Vigan-Womas I, Guillotte M, Le Scanf C, Igonet S, Petres S, Juillerat A, Badaut C, Nato F, Schneider A, Lavergne A, Contamin H, Tall A, Baril L, Bentley GA, Mercereau-Puijalon O.

Infect Immun. 2008 Dec;76(12):5565-80. doi: 10.1128/IAI.00901-08. Epub 2008 Sep 22. Erratum in: Infect Immun. 2009 Feb;77(2):926.

32.

Evaluation of two new commercial tests for the diagnosis of acute dengue virus infection using NS1 antigen detection in human serum.

Dussart P, Petit L, Labeau B, Bremand L, Leduc A, Moua D, Matheus S, Baril L.

PLoS Negl Trop Dis. 2008 Aug 20;2(8):e280. doi: 10.1371/journal.pntd.0000280.

33.

HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.

Tejiokem MC, Gouandjika I, Béniguel L, Zanga MC, Tene G, Gody JC, Njamkepo E, Kfutwah A, Penda I, Bilong C, Rousset D, Pouillot R, Tangy F, Baril L.

PLoS One. 2007 Dec 5;2(12):e1260.

34.

Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus.

Li T, Xie J, He Y, Fan H, Baril L, Qiu Z, Han Y, Xu W, Zhang W, You H, Zuo Y, Fang Q, Yu J, Chen Z, Zhang L.

PLoS One. 2006 Dec 20;1:e24.

35.

Viability and function of 8-day-stored apheresis platelets.

Slichter SJ, Bolgiano D, Jones MK, Christoffel T, Corson J, Rose L, Foley J, Popovsky M, Baril LL, Corda T, Dincecco DM, Snyder EL.

Transfusion. 2006 Oct;46(10):1763-9.

PMID:
17002633
36.

Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum.

Dussart P, Labeau B, Lagathu G, Louis P, Nunes MR, Rodrigues SG, Storck-Herrmann C, Cesaire R, Morvan J, Flamand M, Baril L.

Clin Vaccine Immunol. 2006 Nov;13(11):1185-9. Epub 2006 Sep 20.

37.

Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults.

Baril L, Dietemann J, Essevaz-Roulet M, Béniguel L, Coan P, Briles DE, Guy B, Cozon G.

Clin Exp Immunol. 2006 Aug;145(2):277-86.

38.

Pulmonary tuberculosis and SARS, China.

Liu W, Fontanet A, Zhang PH, Zhan L, Xin ZT, Tang F, Baril L, Cao WC.

Emerg Infect Dis. 2006 Apr;12(4):707-9. No abstract available.

39.

Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome.

Liu W, Fontanet A, Zhang PH, Zhan L, Xin ZT, Baril L, Tang F, Lv H, Cao WC.

J Infect Dis. 2006 Mar 15;193(6):792-5. Epub 2006 Feb 9.

PMID:
16479513
40.

Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries.

Hollingshead SK, Baril L, Ferro S, King J, Coan P, Briles DE; Pneumococcal Proteins Epi Study Group.

J Med Microbiol. 2006 Feb;55(Pt 2):215-21.

PMID:
16434715
41.

Molecular epidemiology of SARS-associated coronavirus, Beijing.

Liu W, Tang F, Fontanet A, Zhan L, Wang TB, Zhang PH, Luan YH, Cao CY, Zhao QM, Wu XM, Xin ZT, Zuo SQ, Baril L, Vabret A, Shao YM, Yang H, Cao WC.

Emerg Infect Dis. 2005 Sep;11(9):1420-4.

42.

Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light.

Snyder E, Raife T, Lin L, Cimino G, Metzel P, Rheinschmidt M, Baril L, Davis K, Buchholz DH, Corash L, Conlan MG.

Transfusion. 2004 Dec;44(12):1732-40.

PMID:
15584988
43.

Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease.

Baril L, Briles DE, Crozier P, King J, Punar M, Hollingshead SK, McCormick JB.

Vaccine. 2004 Dec 21;23(6):789-93.

PMID:
15542203
44.

Long-term SARS coronavirus excretion from patient cohort, China.

Liu W, Tang F, Fontanet A, Zhan L, Zhao QM, Zhang PH, Wu XM, Zuo SQ, Baril L, Vabret A, Xin ZT, Shao YM, Yang H, Cao WC.

Emerg Infect Dis. 2004 Oct;10(10):1841-3.

45.
46.

Natural materno-fetal transfer of antibodies to PspA and to PsaA.

Baril L, Briles DE, Crozier P, King JD, Hollingshead SK, Murphy TF, McCormick JB.

Clin Exp Immunol. 2004 Mar;135(3):474-7.

47.

Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer's disease and control subjects.

Baril L, Nicolas L, Croisile B, Crozier P, Hessler C, Sassolas A, McCormick JB, Trannoy E.

Neurosci Lett. 2004 Jan 30;355(3):226-30.

PMID:
14732472
48.

Collection of two units of leukoreduced RBCs from a single donation with a portable multiple-component collection system.

Snyder EL, Elfath MD, Taylor H, Rugg N, Greenwalt TJ, Baril L, Whitley P, Brantigan B, Story K.

Transfusion. 2003 Dec;43(12):1695-705.

PMID:
14641866
49.
50.

[The relationship between Chlamydia pneumoniae and atherosclerosis].

Gayet A, Baril L, Orfila J.

Presse Med. 2001 Dec 1;30(36):1792-801. Review. French.

PMID:
11771205

Supplemental Content

Support Center